Bone density measurement methods during androgen deprivatio
Recruiting
- Conditions
- Prostate cancer, andogen deprivation, bone densityProstaatkanker, androgeen deprivatie, botdichtheid
- Registration Number
- NL-OMON22104
- Lead Sponsor
- SFG, Rotterdam, The Netherlands
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 51
Inclusion Criteria
Age >18 years
1. Indication for ADT as treatment for nonmetastatic prostate cancer according to the
Bolla schedule;
Exclusion Criteria
Pre-existing indication for osteoporosis treatment, i.e. before the baseline DEXA
scan.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Agreement between the change in Achilles T-scores and the change in DEXA scan<br>T-scores.
- Secondary Outcome Measures
Name Time Method Association of repeated delta T-scores over time of the DEXA and Achilles scans<br /><br>• Association between (absolute) Achilles T-scores and (absolute) DEXA T-scores at<br>each available time point.